Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lisdexamfetamine dose-escalation for methamphetamine dependence
ACTRN12615000391572Phase 2Completed
- Sponsor
- St Vincent's Hospital Sydney
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lisdexamfetamine in methamphetamine use disorder (MUD), sponsored by St Vincent's Hospital Sydney. Started Jun 2015; status: completed.
02
Drugs
lisdexamfetamine
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on ACTRN12615000391572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000391572.